NH Korindo Sekuritas Indonesia
Menu
  • OUR SERVICE
    • News & Research
      • News
      • Equity Report
      • Research Fixed Income
      • Company Report
      • Outlook
      • Special Notation
      • IPO
      • E-IPO
    • Equity
    • Fixed Income
    • Margin
    • Bonds
    • Wealth Management
      • Mutual Funds
    • Download Center
      • Download NAIK
      • Documents
    • Academy
      • Stock Dictionary
      • Stock Education
  • ABOUT US
    • Our Firm
    • Our People
    • Our Branch
    • Corporate Governance
    • Careers
    • FAQ
  • CONTACT
  • Register
  • EN
    • ID
  • ID
  • EN

Kalbe Farma Tbk (KLBF) Stable Growth

  • Author
  • Recent Posts
NHKSI Research Team
NHKSI Research Team
NHKSI Research Team
Latest posts by NHKSI Research Team (see all)
  • Daily Report | 15 July 2026 - July 15, 2026
  • Daily Report | 14 July 2026 - July 14, 2026
  • Daily Report | 13 July 2026 - July 13, 2026

Single-Digit Growth in Sales
KLBF is projected to post the growth of 3.4% in 2018’s sales. The growth is a lot lower than the growth of 4.2% in 2017. It aligns the survey disclosing the decline in Indonesia’s retail sales growth from 3.5% in 2017 to 3.03% y-t-d in 2018.

Adjustment to Selling Prices of Pharmaceutical Drugs
The U.S. dollar strengthening further against the rupiah during 2018 leads to the adjustment to selling prices of pharmaceutical drugs by pharmaceutical companies; KLBF has raised the selling prices of its products by 3%-4% in 3Q18, for example.

Download full report HERE.

Share This Article

Related Article


XA Update Report | PT Charoen Pokphand Indonesia Tbk. (CPIN) – Profitability Soars in 1Q26 , but Expect Normalization Ahead​

23 Jun 2026

CPIN posted a record quarterly net profit of IDR 2.58tn in 1Q26, up +68% YoY (+13% QoQ), as revenue grew +13% YoY (-1% QoQ) to IDR 19.9tn on the back of elevated ASP and higher sales volume amid strong poultry prices.

XA Update Report | PT Bank Mandiri Tbk. (BMRI) – 1Q26 : Solid Earnings Delivery Amid Stable NIM Environment

18 May 2026

Bank Mandiri recorded a strong performance in 1Q26, posting net profit of IDR 15.4T (+16.6% YoY), supported by solid PPOP growth to IDR 22.6T (+10.4% YoY), in line with robust NII expansion of +11.3% YoY to IDR 25.1T

XA Update Report | PT Industri Jamu Dan Farmasi Sido Muncul Tbk. (SIDO) – Inventory Reset in Progress, Rebased Guidance

13 May 2026

1Q26 revenue declined -19% YoY (-53% QoQ) to IDR 640 bn (15% of our FY26F estimates), driven by channel inventory normalization and tighter sell-in discipline following improved distribution visibility.

 

More Article

Daily Report

15 Jul 2026

Daily Report | 15 July 2026

The JCI closed Tuesday's trading by retesting the 6,000 support level, finishing at 6,0...

READ MORE

Daily Report

14 Jul 2026

Daily Report | 14 July 2026

The JCI closed higher on Monday, finishing above the 6,000 level at 6,037.84. The rally...

READ MORE

Daily Report

13 Jul 2026

Daily Report | 13 July 2026

The JCI edged up 0.2% on Friday to close at 5,924.36. The index's movement suggests inv...

READ MORE

Contact Us

  • Treasury Tower 51th Floor, District 8, SCBD Lot 28, Jl. Jend. Sudirman No.Kav 52-53, RT.5/RW.3, Senayan, Kebayoran Baru, South Jakarta City, Jakarta 12190
  • cso@nhsec.co.id
  • +62 21 5088 9100 (Representative Number)
    +62 21 5088 9102 (CS Number)
  • +628 118 198 111 (Official Whatsapp 1)
    +6281 67 0000 5 (Official Whatsapp 2)

Link

  • Our Firm
  • Research
  • Our People
  • Download
  • Dictionary
  • FAQ

Certified By

Data yang ditampilkan di aplikasi PT NH Korindo Sekuritas Indonesia berasal dari BEI dan telah disetujui untuk ditampilkan.

PT NH Korindo Sekuritas Indonesia berizin dan diawasi oleh Otoritas Jasa Keuangan (OJK).


© Copyright 2026 NH Korindo Sekuritas. All rights reserved.

Banner Promo Banner Promo Mobile